LITE Stock, Marvell to Buy Lumentum in $115 Billion AI Deal. What Happens to LITE and MRVL Shareholders?

Marvell Technology (NASDAQ: MRVL) has agreed to acquire Lumentum Holdings (NASDAQ: LITE) in an all-stock transaction with an implied enterprise value of about $115 billion. Lumentum shareholders will receive 4.5 Marvell shares for each Lumentum share they own, which the companies value at roughly $1,132 per LITE share based on October 28, 2026 closing prices. That $1,132 is a reference value, not a cash payment, and the deal is not expected to close until the first half of 2028.

The companies signed a definitive merger agreement on November 1, 2026 and announced the deal on November 2, 2026. Both boards approved it unanimously.

This is a corporate merger, not a lawsuit or a settlement. There is no claim form, no payment deadline and nothing LITE or MRVL holders must file right now.

Quick Facts: Marvell and Lumentum Merger

Detail	Information
Acquirer	Marvell Technology, Inc. (NASDAQ: MRVL)
Target	Lumentum Holdings Inc. (NASDAQ: LITE)
Deal structure	100% stock
Implied enterprise value	About $115 billion
Implied equity value	About $102.54 billion
Exchange ratio	Fixed at 4.500 MRVL shares per LITE share
Implied value per LITE share	About $1,132 (October 28, 2026 closing prices)
Premium	About 23.9% to Lumentum’s unaffected price
Ownership after closing	About 67% Marvell holders, about 33% Lumentum holders (fully diluted)
Cost synergies	More than $1 billion per year at run rate
Combined addressable market (management estimate)	About $550 billion
Leadership	Matt Murphy stays Chairman and CEO
Board	Expands from 7 to 10 seats; Lumentum CEO Michael Hurlston and two other Lumentum directors join
Board approval	Unanimous at both companies
Expected closing	First half of 2028
Votes required	Both companies’ shareholders
Regulatory approval	Required (U.S. and other jurisdictions)
SEC registration	Form S-4 with joint proxy statement/prospectus to be filed
Settlement or claim form	None

The terms come from Marvell’s November 2, 2026 Form 8-K, the merger agreement filed with it, and the companies’ joint announcement. Links are in the sources section below.

What Is the $115 Billion Marvell-Lumentum Deal?

Marvell is buying Lumentum by issuing new Marvell common stock, not by paying cash. Each Lumentum share converts into the right to receive 4.5 Marvell shares when the merger closes.

The $115 billion figure is enterprise value. That measure adds a company’s debt to its equity value and subtracts cash. It describes what the whole business is worth on paper. It is not a check being written to Lumentum shareholders. The equity value, roughly $102.54 billion, is the closer figure to what shareholders collectively receive, and even that is paid in Marvell shares.

How Many Marvell Shares Will LITE Holders Get?

LITE shares owned	MRVL shares at closing
1	4.5
5	22.5
10	45
25	112.5
50	225
100	450
500	2,250
1,000	4,500

The merger agreement provides cash instead of fractional Marvell shares. If your LITE holding produces a fraction of a Marvell share, you receive cash for that fraction. That cash is generally treated differently for tax purposes than the shares themselves (see the tax section below).

Is the $1,132 LITE Stock Value Guaranteed?

No. The companies agreed to a fixed exchange ratio, not a fixed dollar price. Dividing $1,132 by 4.5 shows the reference Marvell price the companies used: about $251.56 per MRVL share (our calculation, not a figure from the filings).

What a LITE share is worth at closing depends on where MRVL trades then:

Hypothetical MRVL price	Value of 4.5 MRVL shares
$150	$675.00
$200	$900.00
$225	$1,012.50
$251.56	$1,132.02 (the reference value)
$275	$1,237.50
$300	$1,350.00

These are illustrations of the contractual math. They are not quotes or predictions.

Because the closing is more than a year away, LITE and MRVL prices will keep moving. A fixed ratio means Lumentum holders carry the risk that Marvell stock falls before closing, and keep the upside if it rises. Until the merger closes, LITE shares remain shares of Lumentum, and the market price reflects both Lumentum’s own business and investors’ estimate of whether the deal will actually close.

Will LITE Stock Stop Trading After the Acquisition?

If the merger closes as agreed, Lumentum stock is converted into Marvell stock and Lumentum becomes part of Marvell. LITE would then stop trading as a separate public company. That happens only at closing, which is expected in 2028. Until then, LITE trades normally.

What the Deal Means for MRVL Stock and Marvell Shareholders

Existing Marvell shareholders keep their shares. They are not being cashed out. But Marvell will issue a large number of new shares, so each existing share represents a smaller slice of a larger company.

Based on the announced 67% / 33% ownership split, Marvell would issue new shares equal to roughly 49% of its pre-deal share count (our calculation: 33 divided by 67). That is why Marvell shareholders get their own vote, explained in the legal section below.

Dilution by itself does not make an acquisition good or bad. What matters is whether Lumentum adds enough revenue, earnings and technology to justify the shares issued. Marvell says it expects the deal to add to non-GAAP earnings per share in the first year after closing. That is a management projection, not a result.

Why Is Marvell Buying Lumentum? The AI Data Center Reason

AI data centers move huge amounts of data between chips, servers and racks. Copper wiring is running into limits on speed, distance and power use at that scale, so the industry is shifting toward optical links that carry data as light.

The two companies cover different halves of that problem:

Marvell supplies custom AI chips, networking and switching silicon, and high-speed electrical and optical interconnect technology. It has also been building up its photonics business, including its earlier agreement to acquire Celestial AI.

Lumentum supplies high-performance lasers, optical transceivers, optical circuit switches and optical components for cloud and AI networks, and runs specialized compound-semiconductor manufacturing, including indium phosphide.

Marvell already buys some optical components from Lumentum. Owning that supply directly lets the combined company design chips and optics together. The companies say this covers “scale-out,” “scale-across,” “scale-up” and eventually “scale-in” connections inside and between data centers, which they estimate expands their addressable market to about $550 billion. That number is a management estimate of the market they could serve. It is not a revenue forecast.

Marvell competes most directly with Broadcom in custom AI silicon and data-center networking, and the deal strengthens its position in optics.

Expected $1 Billion in Cost Synergies

The companies expect more than $1 billion in annual run-rate cost savings, plus better long-term revenue growth and margins. Those savings would come from overlapping R&D, manufacturing, supply chain and corporate costs. None of it has been achieved yet, and the companies have not guaranteed the amount or timing. Investors can check it against actual results after closing.

Who Leads the Combined Company?

Matt Murphy remains Chairman and CEO of Marvell. Lumentum CEO Michael Hurlston and two other Lumentum directors join Marvell’s board, which grows from seven to ten members. Until closing, the two companies operate independently.

Legal Requirements for the Marvell-Lumentum Merger

This section covers the laws and rules that decide whether the deal closes and what rights shareholders have. Always check the final proxy statement/prospectus, because that is where the binding detail sits.

Delaware Corporate Law: Shareholder Votes

Both companies’ filings describe the deal as a merger requiring shareholder approval. Marvell’s amendment of its certificate of incorporation (to increase authorized shares) points to Delaware corporate law, which governs mergers under Section 251 of the Delaware General Corporation Law (DGCL) and charter amendments under Section 242. Confirm each company’s state of incorporation in the S-4.

Two sets of votes are required:

1. Lumentum shareholders must vote to adopt the merger agreement.
2. Marvell shareholders must approve the issuance of the new shares and the charter amendment increasing authorized common stock.

Nasdaq Rule 5635: Why Marvell Holders Vote

Nasdaq Listing Rule 5635(a) generally requires shareholder approval when a listed company issues stock equal to 20% or more of its pre-deal shares in an acquisition. At roughly 49% of its existing share count, this deal clears that line by a wide margin. The new Marvell shares must also be authorized for listing on Nasdaq before closing.

Securities Act of 1933: Form S-4 Registration

Marvell is offering shares to Lumentum’s holders in a merger, which counts as an offer of securities. Under the Securities Act of 1933 (and Rule 145), those shares must be registered with the SEC, normally on Form S-4. The filing doubles as a joint proxy statement and prospectus. Once effective, it is mailed to shareholders before the votes. During the process, the companies’ deal communications are generally filed under SEC Rule 425.

Securities Exchange Act of 1934: Proxy Rules

Soliciting shareholder votes is governed by Section 14(a) of the Securities Exchange Act of 1934 and the SEC’s proxy rules. Rule 14a-9 bars false or misleading statements in proxy materials. This rule is the basis for most shareholder lawsuits filed after merger announcements (see the litigation section below).

Antitrust: Hart-Scott-Rodino Act and Clayton Act Section 7

The deal needs clearance under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act (15 U.S.C. § 18a). Both companies file with the Federal Trade Commission and the Department of Justice, and the deal cannot close until the waiting period expires or ends early. The standard initial waiting period is 30 days. If regulators issue a “second request” for more information, the review can run many months, which is one reason the companies point to 2028.

Regulators review the merger under Section 7 of the Clayton Act (15 U.S.C. § 18), which bars acquisitions that may substantially lessen competition, and under Section 1 of the Sherman Act. The central questions are likely to be whether combining a leading chip supplier with a leading optical-component supplier lets the company disadvantage rival chipmakers or customers, and how hyperscale buyers of both products are affected.

Both companies sell globally, so approvals from regulators outside the U.S. are also required. The companies’ announcement lists “other regulatory clearances.” Which foreign authorities must sign off will be detailed in the S-4. Do not assume the list; check the filing.

Delaware Appraisal Rights

Appraisal rights let some shareholders ask a court to set the “fair value” of their shares instead of accepting merger consideration. Under DGCL Section 262, appraisal is generally not available for shares listed on a national exchange when holders receive only stock of a listed company plus cash in place of fractional shares. That description appears to fit this deal, so LITE holders probably do not have appraisal rights. The joint proxy statement will say definitively, so read that section.

Board Fiduciary Duties

Under Delaware law, directors owe duties of care and loyalty. Courts generally review a stock-for-stock merger between widely held companies under the deferential business judgment rule, though plaintiffs sometimes challenge process or conflicts. The proxy statement’s “Background of the Merger” section, which describes how the deal was negotiated, is where such questions are tested.

Tax Treatment

The tax consequences for LITE holders depend on how the merger is structured. Stock-for-stock mergers are often designed to qualify as tax-free reorganizations under Section 368(a) of the Internal Revenue Code, in which case shareholders generally do not recognize gain or loss on the shares they receive. Cash received in place of a fractional share is typically taxable. The materials we reviewed do not confirm the intended tax treatment, so do not assume it. The S-4 will contain a tax section, and each holder should confirm the result with a tax professional.

Forward-Looking Statements and the PSLRA Safe Harbor

The synergy, growth and market-size numbers are forward-looking. The Private Securities Litigation Reform Act of 1995 gives companies a statutory safe harbor for forward-looking statements that carry meaningful cautionary language, which is why the announcement lists risk factors. It does not shield statements of present fact that turn out to be false.

Insider Trading Rules

Anyone who learns confidential merger information through a job, advisory role or a tip cannot lawfully trade on it. Insider trading is prohibited under Section 10(b) of the Exchange Act and Rule 10b-5. Merger announcements are a common source of enforcement cases.

What Happens If the Marvell-Lumentum Deal Falls Through?

The merger can be terminated in defined situations, such as a failed shareholder vote or missing regulatory approvals. The agreement sets these fees:

Fee	Amount	Paid by
Termination fee	$5.8 billion	Marvell, in specified circumstances
Termination fee	$2.9 billion	Lumentum, in corresponding circumstances
Regulatory termination fee	$3.2 billion	Marvell, if the agreement’s regulatory-failure conditions are met

These fees are not automatic. They apply only when the agreement’s specific triggers occur.

The contract’s initial outside date is November 1, 2027. It can extend automatically to February 1, May 1 and August 1, 2028 if regulatory approvals are still pending. That is a legal deadline, separate from the companies’ first-half 2028 target for closing.

If the deal fails, LITE shares are not converted, and Lumentum remains an independent public company unless another transaction occurs.

Closing Conditions Checklist

• Lumentum shareholder vote adopting the merger agreement
• Marvell shareholder vote approving the share issuance and charter amendment
• Expiration or termination of the HSR waiting period, and other required approvals
• SEC declaring the Form S-4 effective
• Nasdaq authorization to list the new Marvell shares
• No legal order blocking the merger, and customary representation and covenant conditions

Shareholder Lawsuits and Law Firm Notices After Merger Announcements

After large mergers, investors often see ads or emails from law firms saying they are “investigating” the deal. An investigation notice is not a lawsuit and not a settlement, and it does not mean anything was done wrong.

Merger-related suits, when they are filed, usually claim that the proxy statement omitted or misstated something material (Section 14(a) and Rule 14a-9, with control-person claims under Section 20(a)). Many are resolved by additional disclosures before the vote, and some individual shareholder demands are filed privately without a court case. As of November 2, 2026, we have not seen any lawsuit over this merger in the materials reviewed. Check the SEC’s EDGAR system and court dockets for updates.

This deal is also separate from investor fraud lawsuits against other AI and technology companies. For example, see:

• POET Technologies Class Action Did You Lose Money On POET Stock?
• Super Micro Computer (SMCI) Investors Lost Money A Federal Fraud Lawsuit Says the Company Hid a $2.5 Billion Illegal Scheme

Those cases involve different companies and different allegations. Nothing in them suggests wrongdoing by Marvell or Lumentum.

What Should LITE and MRVL Shareholders Do Now?

Nothing is required right now. There is no form to submit and no deadline to meet. Practical steps:

1. Watch for the Form S-4 and joint proxy statement, which will set out vote dates, the record date and your rights.
2. Vote when you receive your proxy materials, if you hold shares on the record date.
3. Check your brokerage for how stock awards and fractional shares are handled.
4. Talk to a tax professional before selling or holding through the merger.
5. Be cautious of scam messages. No legitimate merger process asks for your account password or a fee to “claim” shares.

If you hold Lumentum stock options or restricted stock units, the 8-K describes how equity awards are treated. Read that section of the merger agreement.

What to Watch Next

• Filing of the Form S-4 and the dates for both shareholder meetings
• HSR waiting period and any second request from the FTC or DOJ
• Foreign regulatory filings and conditions
• MRVL price moves, which change the value of what LITE holders receive
• Lumentum’s quarterly results while it stays independent
• Progress on the $1 billion synergy target and the roadmap for next-generation optical products
• Reactions from hyperscale customers that buy both silicon and optics

Key Dates

Date	Event
October 28, 2026	Reference closing prices for the valuation
November 1, 2026	Definitive merger agreement signed
November 2, 2026	Deal announced; Marvell files Form 8-K
Next	Form S-4 and joint proxy statement filed
2027 to 2028	Shareholder votes and regulatory review
November 1, 2027	Initial outside date
February 1, 2028	First automatic extension, if conditions apply
May 1, 2028	Second automatic extension, if conditions apply
First half of 2028	Companies’ expected closing
August 1, 2028	Final potential extension

Frequently Asked Questions About the Marvell and Lumentum Merger

Is Marvell paying cash for Lumentum?

 No. It is an all-stock deal. LITE holders receive 4.5 MRVL shares per LITE share, plus cash only for fractional shares.

Is LITE stock worth $1,132?

 That is the implied value using October 28, 2026 closing prices. The real value moves with the MRVL price until closing.

When will the Marvell-Lumentum acquisition close?

 The companies expect the first half of 2028, subject to shareholder votes and regulatory approval.

Will I owe taxes on my LITE shares because of the merger?

 It depends on the merger’s final tax treatment and your situation. The S-4 will have the tax discussion. Confirm with a tax professional.

Do LITE shareholders have appraisal rights? 

Probably not, because the consideration is listed stock plus cash for fractions, which generally falls outside DGCL Section 262 appraisal. The proxy statement will confirm.

Do MRVL shareholders vote? 

Yes. They must approve the share issuance and the charter amendment, as required by Delaware law and Nasdaq Rule 5635.

Can the deal be blocked? 

Yes. Antitrust regulators can challenge or condition it, and shareholders can vote it down.

Is there a class action or settlement I can join? No. This is a merger announcement, not a lawsuit settlement.

Who runs the combined company?

 Matt Murphy remains Chairman and CEO. Three Lumentum directors join the board.

Official Sources

1. Marvell Form 8-K, November 2, 2026
2. Exhibit 2.1, Agreement and Plan of Merger
3. Exhibit 99.1, Marvell and Lumentum to Combine
4. Marvell investor relations
5. Lumentum investor relations
6. SEC EDGAR: Marvell Technology, CIK 1835632 and Lumentum Holdings, CIK 1633978

Statutes and rules referenced: Securities Act of 1933 and Rule 145; Securities Exchange Act of 1934 Sections 10(b), 14(a), 20(a), Rules 10b-5, 14a-9 and SEC Rule 425; Hart-Scott-Rodino Act (15 U.S.C. § 18a); Clayton Act Section 7 (15 U.S.C. § 18); Sherman Act Section 1; Delaware General Corporation Law Sections 242, 251 and 262; Nasdaq Listing Rule 5635(a); Internal Revenue Code Section 368(a); Private Securities Litigation Reform Act of 1995.

Update Log

Date	Update
November 2, 2026	Article published following the Form 8-K and joint announcement

About the Author

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against Marvell’s November 2, 2026 Form 8-K, the Agreement and Plan of Merger, and the companies’ joint announcement, as of November 2, 2026. Last Updated: November 2, 2026.

This article is for informational purposes only and does not constitute legal, tax or investment advice. Laws vary by state and individual circumstances differ. Stock prices fluctuate, merger consideration is governed by the merger agreement, and the acquisition may not close. Projected synergies and market opportunities are management expectations, not guarantees. For advice about your specific situation, consult a qualified attorney, tax professional or financial advisor.